nodes	percent_of_prediction	percent_of_DWPC	metapath
Abiraterone—ALB—chronic obstructive pulmonary disease	0.282	1	CbGaD
Abiraterone—Testosterone—Prednisolone—chronic obstructive pulmonary disease	0.218	1	CrCrCtD
Abiraterone—CYP2C8—Montelukast—chronic obstructive pulmonary disease	0.0472	0.15	CbGbCtD
Abiraterone—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0397	0.126	CbGbCtD
Abiraterone—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0397	0.126	CbGbCtD
Abiraterone—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.0354	0.113	CbGbCtD
Abiraterone—ALB—Prednisone—chronic obstructive pulmonary disease	0.0339	0.108	CbGbCtD
Abiraterone—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0334	0.106	CbGbCtD
Abiraterone—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0225	0.0717	CbGbCtD
Abiraterone—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0215	0.0684	CbGbCtD
Abiraterone—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0192	0.0609	CbGbCtD
Abiraterone—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0112	0.0358	CbGbCtD
Abiraterone—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0106	0.0338	CbGbCtD
Abiraterone—Nocturia—Arformoterol—chronic obstructive pulmonary disease	0.00114	0.00912	CcSEcCtD
Abiraterone—Urinary tract infection—Roflumilast—chronic obstructive pulmonary disease	0.00113	0.00906	CcSEcCtD
Abiraterone—Chest discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00112	0.00903	CcSEcCtD
Abiraterone—Blood potassium decreased—Prednisone—chronic obstructive pulmonary disease	0.00109	0.00876	CcSEcCtD
Abiraterone—Hypernatraemia—Prednisolone—chronic obstructive pulmonary disease	0.00108	0.00871	CcSEcCtD
Abiraterone—Connective tissue disorder—Roflumilast—chronic obstructive pulmonary disease	0.00102	0.00822	CcSEcCtD
Abiraterone—Cardiac disorder—Roflumilast—chronic obstructive pulmonary disease	0.000967	0.00777	CcSEcCtD
Abiraterone—Mediastinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.000939	0.00754	CcSEcCtD
Abiraterone—Hypokalaemia—Aminophylline—chronic obstructive pulmonary disease	0.000914	0.00734	CcSEcCtD
Abiraterone—Mental disorder—Roflumilast—chronic obstructive pulmonary disease	0.000913	0.00733	CcSEcCtD
Abiraterone—Lymphopenia—Prednisone—chronic obstructive pulmonary disease	0.00081	0.0065	CcSEcCtD
Abiraterone—Hypernatraemia—Prednisone—chronic obstructive pulmonary disease	0.000788	0.00633	CcSEcCtD
Abiraterone—Hyperglycaemia—Aminophylline—chronic obstructive pulmonary disease	0.000783	0.00629	CcSEcCtD
Abiraterone—Myalgia—Roflumilast—chronic obstructive pulmonary disease	0.000772	0.0062	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Roflumilast—chronic obstructive pulmonary disease	0.000767	0.00616	CcSEcCtD
Abiraterone—Discomfort—Roflumilast—chronic obstructive pulmonary disease	0.000763	0.00613	CcSEcCtD
Abiraterone—Upper respiratory tract infection—Tiotropium—chronic obstructive pulmonary disease	0.000761	0.00611	CcSEcCtD
Abiraterone—Hyperglycaemia—Tiotropium—chronic obstructive pulmonary disease	0.000739	0.00593	CcSEcCtD
Abiraterone—Haematuria—Aminophylline—chronic obstructive pulmonary disease	0.000738	0.00593	CcSEcCtD
Abiraterone—Infection—Roflumilast—chronic obstructive pulmonary disease	0.000735	0.00591	CcSEcCtD
Abiraterone—Hypertriglyceridaemia—Prednisone—chronic obstructive pulmonary disease	0.000722	0.0058	CcSEcCtD
Abiraterone—Skin disorder—Roflumilast—chronic obstructive pulmonary disease	0.000719	0.00577	CcSEcCtD
Abiraterone—Multiple fractures—Prednisone—chronic obstructive pulmonary disease	0.000713	0.00573	CcSEcCtD
Abiraterone—Fracture—Prednisone—chronic obstructive pulmonary disease	0.000713	0.00573	CcSEcCtD
Abiraterone—Urinary tract infection—Tiotropium—chronic obstructive pulmonary disease	0.00071	0.0057	CcSEcCtD
Abiraterone—Hypokalaemia—Formoterol—chronic obstructive pulmonary disease	0.000696	0.00559	CcSEcCtD
Abiraterone—Hypokalaemia—Arformoterol—chronic obstructive pulmonary disease	0.000696	0.00559	CcSEcCtD
Abiraterone—Nasopharyngitis—Arformoterol—chronic obstructive pulmonary disease	0.000684	0.00549	CcSEcCtD
Abiraterone—Nasopharyngitis—Formoterol—chronic obstructive pulmonary disease	0.000684	0.00549	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Roflumilast—chronic obstructive pulmonary disease	0.000674	0.00542	CcSEcCtD
Abiraterone—Aspartate aminotransferase increased—Montelukast—chronic obstructive pulmonary disease	0.000674	0.00541	CcSEcCtD
Abiraterone—Nasopharyngitis—Montelukast—chronic obstructive pulmonary disease	0.00067	0.00538	CcSEcCtD
Abiraterone—Insomnia—Roflumilast—chronic obstructive pulmonary disease	0.00067	0.00538	CcSEcCtD
Abiraterone—Alanine aminotransferase increased—Montelukast—chronic obstructive pulmonary disease	0.00066	0.0053	CcSEcCtD
Abiraterone—Hypokalaemia—Salbutamol—chronic obstructive pulmonary disease	0.000657	0.00528	CcSEcCtD
Abiraterone—Dyspepsia—Roflumilast—chronic obstructive pulmonary disease	0.000652	0.00523	CcSEcCtD
Abiraterone—Urinary tract disorder—Tiotropium—chronic obstructive pulmonary disease	0.000647	0.0052	CcSEcCtD
Abiraterone—Nasopharyngitis—Salbutamol—chronic obstructive pulmonary disease	0.000645	0.00518	CcSEcCtD
Abiraterone—Connective tissue disorder—Tiotropium—chronic obstructive pulmonary disease	0.000644	0.00517	CcSEcCtD
Abiraterone—Urethral disorder—Tiotropium—chronic obstructive pulmonary disease	0.000642	0.00516	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.000639	0.00513	CcSEcCtD
Abiraterone—Fatigue—Roflumilast—chronic obstructive pulmonary disease	0.000638	0.00513	CcSEcCtD
Abiraterone—Constipation—Roflumilast—chronic obstructive pulmonary disease	0.000633	0.00508	CcSEcCtD
Abiraterone—Blood triglycerides increased—Prednisone—chronic obstructive pulmonary disease	0.000633	0.00508	CcSEcCtD
Abiraterone—Arrhythmia—Aminophylline—chronic obstructive pulmonary disease	0.000621	0.00499	CcSEcCtD
Abiraterone—Upper respiratory tract infection—Formoterol—chronic obstructive pulmonary disease	0.000614	0.00493	CcSEcCtD
Abiraterone—Upper respiratory tract infection—Arformoterol—chronic obstructive pulmonary disease	0.000614	0.00493	CcSEcCtD
Abiraterone—Upper respiratory tract infection—Montelukast—chronic obstructive pulmonary disease	0.000601	0.00483	CcSEcCtD
Abiraterone—Hyperglycaemia—Arformoterol—chronic obstructive pulmonary disease	0.000596	0.00479	CcSEcCtD
Abiraterone—Hyperglycaemia—Formoterol—chronic obstructive pulmonary disease	0.000596	0.00479	CcSEcCtD
Abiraterone—Angiopathy—Tiotropium—chronic obstructive pulmonary disease	0.000595	0.00477	CcSEcCtD
Abiraterone—Mediastinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000591	0.00474	CcSEcCtD
Abiraterone—Arrhythmia—Tiotropium—chronic obstructive pulmonary disease	0.000585	0.0047	CcSEcCtD
Abiraterone—Acute coronary syndrome—Formoterol—chronic obstructive pulmonary disease	0.000581	0.00466	CcSEcCtD
Abiraterone—Acute coronary syndrome—Arformoterol—chronic obstructive pulmonary disease	0.000581	0.00466	CcSEcCtD
Abiraterone—Pneumonia—Montelukast—chronic obstructive pulmonary disease	0.00058	0.00466	CcSEcCtD
Abiraterone—Upper respiratory tract infection—Salbutamol—chronic obstructive pulmonary disease	0.00058	0.00466	CcSEcCtD
Abiraterone—Myocardial infarction—Arformoterol—chronic obstructive pulmonary disease	0.000577	0.00464	CcSEcCtD
Abiraterone—Myocardial infarction—Formoterol—chronic obstructive pulmonary disease	0.000577	0.00464	CcSEcCtD
Abiraterone—Infestation NOS—Montelukast—chronic obstructive pulmonary disease	0.000577	0.00463	CcSEcCtD
Abiraterone—Infestation—Montelukast—chronic obstructive pulmonary disease	0.000577	0.00463	CcSEcCtD
Abiraterone—Mental disorder—Tiotropium—chronic obstructive pulmonary disease	0.000574	0.00461	CcSEcCtD
Abiraterone—Urinary tract infection—Arformoterol—chronic obstructive pulmonary disease	0.000573	0.0046	CcSEcCtD
Abiraterone—Urinary tract infection—Formoterol—chronic obstructive pulmonary disease	0.000573	0.0046	CcSEcCtD
Abiraterone—Hyperglycaemia—Salbutamol—chronic obstructive pulmonary disease	0.000563	0.00452	CcSEcCtD
Abiraterone—Haematuria—Arformoterol—chronic obstructive pulmonary disease	0.000562	0.00451	CcSEcCtD
Abiraterone—Haematuria—Formoterol—chronic obstructive pulmonary disease	0.000562	0.00451	CcSEcCtD
Abiraterone—Fluid retention—Prednisolone—chronic obstructive pulmonary disease	0.000541	0.00435	CcSEcCtD
Abiraterone—Urinary tract infection—Salbutamol—chronic obstructive pulmonary disease	0.000541	0.00434	CcSEcCtD
Abiraterone—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.000531	0.00427	CcSEcCtD
Abiraterone—Haematuria—Salbutamol—chronic obstructive pulmonary disease	0.00053	0.00426	CcSEcCtD
Abiraterone—Urinary tract disorder—Formoterol—chronic obstructive pulmonary disease	0.000522	0.00419	CcSEcCtD
Abiraterone—Urinary tract disorder—Arformoterol—chronic obstructive pulmonary disease	0.000522	0.00419	CcSEcCtD
Abiraterone—Connective tissue disorder—Arformoterol—chronic obstructive pulmonary disease	0.00052	0.00417	CcSEcCtD
Abiraterone—Connective tissue disorder—Formoterol—chronic obstructive pulmonary disease	0.00052	0.00417	CcSEcCtD
Abiraterone—Urethral disorder—Formoterol—chronic obstructive pulmonary disease	0.000518	0.00416	CcSEcCtD
Abiraterone—Urethral disorder—Arformoterol—chronic obstructive pulmonary disease	0.000518	0.00416	CcSEcCtD
Abiraterone—Urinary tract disorder—Montelukast—chronic obstructive pulmonary disease	0.000512	0.00411	CcSEcCtD
Abiraterone—Connective tissue disorder—Montelukast—chronic obstructive pulmonary disease	0.000509	0.00409	CcSEcCtD
Abiraterone—Urethral disorder—Montelukast—chronic obstructive pulmonary disease	0.000508	0.00408	CcSEcCtD
Abiraterone—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.000507	0.00407	CcSEcCtD
Abiraterone—Cough—Tiotropium—chronic obstructive pulmonary disease	0.000498	0.004	CcSEcCtD
Abiraterone—Urinary tract disorder—Salbutamol—chronic obstructive pulmonary disease	0.000493	0.00396	CcSEcCtD
Abiraterone—Hypertension—Tiotropium—chronic obstructive pulmonary disease	0.000493	0.00396	CcSEcCtD
Abiraterone—Cardiac disorder—Formoterol—chronic obstructive pulmonary disease	0.000491	0.00394	CcSEcCtD
Abiraterone—Cardiac disorder—Arformoterol—chronic obstructive pulmonary disease	0.000491	0.00394	CcSEcCtD
Abiraterone—Connective tissue disorder—Salbutamol—chronic obstructive pulmonary disease	0.000491	0.00394	CcSEcCtD
Abiraterone—Infection—Aminophylline—chronic obstructive pulmonary disease	0.00049	0.00394	CcSEcCtD
Abiraterone—Urethral disorder—Salbutamol—chronic obstructive pulmonary disease	0.00049	0.00393	CcSEcCtD
Abiraterone—Chest pain—Tiotropium—chronic obstructive pulmonary disease	0.000486	0.0039	CcSEcCtD
Abiraterone—Myalgia—Tiotropium—chronic obstructive pulmonary disease	0.000486	0.0039	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Tiotropium—chronic obstructive pulmonary disease	0.000482	0.00387	CcSEcCtD
Abiraterone—Cardiac disorder—Montelukast—chronic obstructive pulmonary disease	0.000481	0.00386	CcSEcCtD
Abiraterone—Mediastinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000477	0.00383	CcSEcCtD
Abiraterone—Mediastinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000477	0.00383	CcSEcCtD
Abiraterone—Contusion—Prednisone—chronic obstructive pulmonary disease	0.000475	0.00381	CcSEcCtD
Abiraterone—Arrhythmia—Arformoterol—chronic obstructive pulmonary disease	0.000472	0.00379	CcSEcCtD
Abiraterone—Arrhythmia—Formoterol—chronic obstructive pulmonary disease	0.000472	0.00379	CcSEcCtD
Abiraterone—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.000471	0.00378	CcSEcCtD
Abiraterone—Mediastinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000467	0.00375	CcSEcCtD
Abiraterone—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000467	0.00375	CcSEcCtD
Abiraterone—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000466	0.00374	CcSEcCtD
Abiraterone—Oedema—Tiotropium—chronic obstructive pulmonary disease	0.000466	0.00374	CcSEcCtD
Abiraterone—Cardiac disorder—Salbutamol—chronic obstructive pulmonary disease	0.000463	0.00372	CcSEcCtD
Abiraterone—Mental disorder—Arformoterol—chronic obstructive pulmonary disease	0.000463	0.00372	CcSEcCtD
Abiraterone—Mental disorder—Formoterol—chronic obstructive pulmonary disease	0.000463	0.00372	CcSEcCtD
Abiraterone—Infection—Tiotropium—chronic obstructive pulmonary disease	0.000463	0.00371	CcSEcCtD
Abiraterone—Mental disorder—Montelukast—chronic obstructive pulmonary disease	0.000454	0.00364	CcSEcCtD
Abiraterone—Angiopathy—Salbutamol—chronic obstructive pulmonary disease	0.000453	0.00364	CcSEcCtD
Abiraterone—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.000452	0.00363	CcSEcCtD
Abiraterone—Mediastinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.00045	0.00361	CcSEcCtD
Abiraterone—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.000447	0.00359	CcSEcCtD
Abiraterone—Arrhythmia—Salbutamol—chronic obstructive pulmonary disease	0.000446	0.00358	CcSEcCtD
Abiraterone—Hypercholesterolaemia—Prednisone—chronic obstructive pulmonary disease	0.000438	0.00352	CcSEcCtD
Abiraterone—Mental disorder—Salbutamol—chronic obstructive pulmonary disease	0.000438	0.00351	CcSEcCtD
Abiraterone—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.000435	0.00349	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.000424	0.00341	CcSEcCtD
Abiraterone—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.000421	0.00338	CcSEcCtD
Abiraterone—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.00041	0.00329	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000402	0.00323	CcSEcCtD
Abiraterone—Cough—Formoterol—chronic obstructive pulmonary disease	0.000402	0.00323	CcSEcCtD
Abiraterone—Cough—Arformoterol—chronic obstructive pulmonary disease	0.000402	0.00323	CcSEcCtD
Abiraterone—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000398	0.0032	CcSEcCtD
Abiraterone—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.000397	0.00319	CcSEcCtD
Abiraterone—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.000397	0.00319	CcSEcCtD
Abiraterone—Cough—Montelukast—chronic obstructive pulmonary disease	0.000394	0.00316	CcSEcCtD
Abiraterone—Fluid retention—Prednisone—chronic obstructive pulmonary disease	0.000393	0.00316	CcSEcCtD
Abiraterone—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000392	0.00315	CcSEcCtD
Abiraterone—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000392	0.00315	CcSEcCtD
Abiraterone—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000392	0.00315	CcSEcCtD
Abiraterone—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000392	0.00315	CcSEcCtD
Abiraterone—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.00039	0.00313	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000389	0.00313	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000389	0.00313	CcSEcCtD
Abiraterone—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000387	0.00311	CcSEcCtD
Abiraterone—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000387	0.00311	CcSEcCtD
Abiraterone—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000384	0.00308	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000381	0.00306	CcSEcCtD
Abiraterone—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000379	0.00305	CcSEcCtD
Abiraterone—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000376	0.00302	CcSEcCtD
Abiraterone—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000376	0.00302	CcSEcCtD
Abiraterone—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000375	0.00301	CcSEcCtD
Abiraterone—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000373	0.003	CcSEcCtD
Abiraterone—Infection—Formoterol—chronic obstructive pulmonary disease	0.000373	0.003	CcSEcCtD
Abiraterone—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.00037	0.00297	CcSEcCtD
Abiraterone—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.00037	0.00297	CcSEcCtD
Abiraterone—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000368	0.00296	CcSEcCtD
Abiraterone—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000366	0.00294	CcSEcCtD
Abiraterone—Infection—Montelukast—chronic obstructive pulmonary disease	0.000366	0.00294	CcSEcCtD
Abiraterone—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000365	0.00293	CcSEcCtD
Abiraterone—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000365	0.00293	CcSEcCtD
Abiraterone—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000357	0.00287	CcSEcCtD
Abiraterone—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000355	0.00285	CcSEcCtD
Abiraterone—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000352	0.00283	CcSEcCtD
Abiraterone—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000345	0.00277	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000342	0.00275	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000342	0.00275	CcSEcCtD
Abiraterone—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.00034	0.00273	CcSEcCtD
Abiraterone—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.00034	0.00273	CcSEcCtD
Abiraterone—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000338	0.00271	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000335	0.00269	CcSEcCtD
Abiraterone—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000335	0.00269	CcSEcCtD
Abiraterone—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000335	0.00269	CcSEcCtD
Abiraterone—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000333	0.00267	CcSEcCtD
Abiraterone—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000331	0.00266	CcSEcCtD
Abiraterone—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000331	0.00266	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000324	0.0026	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000324	0.0026	CcSEcCtD
Abiraterone—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000324	0.0026	CcSEcCtD
Abiraterone—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000324	0.0026	CcSEcCtD
Abiraterone—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000324	0.0026	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000323	0.0026	CcSEcCtD
Abiraterone—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000321	0.00258	CcSEcCtD
Abiraterone—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000321	0.00258	CcSEcCtD
Abiraterone—Testosterone—CYP1A1—chronic obstructive pulmonary disease	0.000321	0.642	CrCbGaD
Abiraterone—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000321	0.00258	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000318	0.00255	CcSEcCtD
Abiraterone—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000317	0.00255	CcSEcCtD
Abiraterone—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000316	0.00254	CcSEcCtD
Abiraterone—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000315	0.00253	CcSEcCtD
Abiraterone—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000314	0.00252	CcSEcCtD
Abiraterone—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000313	0.00251	CcSEcCtD
Abiraterone—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000312	0.00251	CcSEcCtD
Abiraterone—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000311	0.0025	CcSEcCtD
Abiraterone—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000311	0.0025	CcSEcCtD
Abiraterone—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	0.000308	0.00248	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000306	0.00246	CcSEcCtD
Abiraterone—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000306	0.00246	CcSEcCtD
Abiraterone—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000303	0.00244	CcSEcCtD
Abiraterone—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000297	0.00239	CcSEcCtD
Abiraterone—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000297	0.00239	CcSEcCtD
Abiraterone—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000296	0.00238	CcSEcCtD
Abiraterone—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000294	0.00236	CcSEcCtD
Abiraterone—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000293	0.00236	CcSEcCtD
Abiraterone—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000291	0.00234	CcSEcCtD
Abiraterone—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.00028	0.00225	CcSEcCtD
Abiraterone—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	0.000274	0.0022	CcSEcCtD
Abiraterone—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.00027	0.00216	CcSEcCtD
Abiraterone—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.00027	0.00216	CcSEcCtD
Abiraterone—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	0.000265	0.00213	CcSEcCtD
Abiraterone—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000264	0.00212	CcSEcCtD
Abiraterone—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000257	0.00206	CcSEcCtD
Abiraterone—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000257	0.00206	CcSEcCtD
Abiraterone—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000256	0.00205	CcSEcCtD
Abiraterone—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000255	0.00204	CcSEcCtD
Abiraterone—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000252	0.00202	CcSEcCtD
Abiraterone—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000243	0.00195	CcSEcCtD
Abiraterone—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000239	0.00192	CcSEcCtD
Abiraterone—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000239	0.00192	CcSEcCtD
Abiraterone—Rash—Formoterol—chronic obstructive pulmonary disease	0.000237	0.0019	CcSEcCtD
Abiraterone—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000237	0.0019	CcSEcCtD
Abiraterone—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000237	0.0019	CcSEcCtD
Abiraterone—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000237	0.0019	CcSEcCtD
Abiraterone—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.000235	0.00188	CcSEcCtD
Abiraterone—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000234	0.00188	CcSEcCtD
Abiraterone—Rash—Montelukast—chronic obstructive pulmonary disease	0.000232	0.00186	CcSEcCtD
Abiraterone—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000232	0.00186	CcSEcCtD
Abiraterone—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.000229	0.00184	CcSEcCtD
Abiraterone—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.000227	0.00182	CcSEcCtD
Abiraterone—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000226	0.00181	CcSEcCtD
Abiraterone—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000224	0.0018	CcSEcCtD
Abiraterone—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000223	0.00179	CcSEcCtD
Abiraterone—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000215	0.00173	CcSEcCtD
Abiraterone—CYP2D6—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	0.000211	0.00348	CbGpPWpGaD
Abiraterone—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.00021	0.00168	CcSEcCtD
Abiraterone—ALB—Folate Metabolism—MPO—chronic obstructive pulmonary disease	0.000209	0.00345	CbGpPWpGaD
Abiraterone—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000208	0.00343	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000205	0.00338	CbGpPWpGaD
Abiraterone—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000205	0.00164	CcSEcCtD
Abiraterone—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000203	0.00163	CcSEcCtD
Abiraterone—CYP17A1—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000202	0.00333	CbGpPWpGaD
Abiraterone—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.0002	0.00329	CbGpPWpGaD
Abiraterone—ABCC1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.0002	0.00329	CbGpPWpGaD
Abiraterone—CYP17A1—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000199	0.00329	CbGpPWpGaD
Abiraterone—CYP2D6—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	0.000198	0.00326	CbGpPWpGaD
Abiraterone—ALB—Platelet degranulation—SERPINA1—chronic obstructive pulmonary disease	0.00019	0.00314	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	0.00019	0.00314	CbGpPWpGaD
Abiraterone—CYP2C8—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.00019	0.00313	CbGpPWpGaD
Abiraterone—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000189	0.00312	CbGpPWpGaD
Abiraterone—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000189	0.00152	CcSEcCtD
Abiraterone—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.000186	0.00149	CcSEcCtD
Abiraterone—CYP17A1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000186	0.00306	CbGpPWpGaD
Abiraterone—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000185	0.00306	CbGpPWpGaD
Abiraterone—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000184	0.00148	CcSEcCtD
Abiraterone—CYP17A1—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000183	0.00302	CbGpPWpGaD
Abiraterone—CYP2C8—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000183	0.00302	CbGpPWpGaD
Abiraterone—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000182	0.00146	CcSEcCtD
Abiraterone—ALB—Response to elevated platelet cytosolic Ca2+—SERPINA1—chronic obstructive pulmonary disease	0.000181	0.00299	CbGpPWpGaD
Abiraterone—Testosterone—ALB—chronic obstructive pulmonary disease	0.000179	0.358	CrCbGaD
Abiraterone—SULT2A1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000177	0.00292	CbGpPWpGaD
Abiraterone—CYP17A1—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000176	0.0029	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	0.000175	0.00289	CbGpPWpGaD
Abiraterone—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000174	0.00287	CbGpPWpGaD
Abiraterone—CYP17A1—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000174	0.00286	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—GC—chronic obstructive pulmonary disease	0.000172	0.00284	CbGpPWpGaD
Abiraterone—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000167	0.00276	CbGpPWpGaD
Abiraterone—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000167	0.00134	CcSEcCtD
Abiraterone—ALB—Selenium Micronutrient Network—MPO—chronic obstructive pulmonary disease	0.000166	0.00274	CbGpPWpGaD
Abiraterone—ALB—Platelet degranulation—TGFB2—chronic obstructive pulmonary disease	0.000165	0.00272	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.00016	0.00264	CbGpPWpGaD
Abiraterone—ALB—Response to elevated platelet cytosolic Ca2+—TGFB2—chronic obstructive pulmonary disease	0.000157	0.00259	CbGpPWpGaD
Abiraterone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000157	0.00258	CbGpPWpGaD
Abiraterone—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000156	0.00126	CcSEcCtD
Abiraterone—CYP2C8—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000156	0.00257	CbGpPWpGaD
Abiraterone—CYP2D6—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000156	0.00257	CbGpPWpGaD
Abiraterone—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000154	0.00124	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000153	0.00123	CcSEcCtD
Abiraterone—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000152	0.00122	CcSEcCtD
Abiraterone—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000152	0.00251	CbGpPWpGaD
Abiraterone—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.00015	0.00248	CbGpPWpGaD
Abiraterone—CYP2D6—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.00015	0.00248	CbGpPWpGaD
Abiraterone—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000148	0.00119	CcSEcCtD
Abiraterone—ALB—Platelet activation, signaling and aggregation—RAPGEF3—chronic obstructive pulmonary disease	0.000147	0.00243	CbGpPWpGaD
Abiraterone—Infection—Prednisone—chronic obstructive pulmonary disease	0.000147	0.00118	CcSEcCtD
Abiraterone—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000144	0.00115	CcSEcCtD
Abiraterone—CYP17A1—Metabolism—APIP—chronic obstructive pulmonary disease	0.000142	0.00234	CbGpPWpGaD
Abiraterone—ALB—Vitamin B12 Metabolism—CRP—chronic obstructive pulmonary disease	0.000135	0.00223	CbGpPWpGaD
Abiraterone—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000135	0.00222	CbGpPWpGaD
Abiraterone—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000135	0.00108	CcSEcCtD
Abiraterone—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000134	0.00107	CcSEcCtD
Abiraterone—CYP2C8—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000133	0.00219	CbGpPWpGaD
Abiraterone—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.00013	0.00105	CcSEcCtD
Abiraterone—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000128	0.00103	CcSEcCtD
Abiraterone—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000128	0.00103	CcSEcCtD
Abiraterone—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000127	0.00102	CcSEcCtD
Abiraterone—SULT2A1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	0.000127	0.0021	CbGpPWpGaD
Abiraterone—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000126	0.00102	CcSEcCtD
Abiraterone—ABCC1—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000124	0.00204	CbGpPWpGaD
Abiraterone—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000123	0.00203	CbGpPWpGaD
Abiraterone—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000123	0.00203	CbGpPWpGaD
Abiraterone—ALB—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000122	0.002	CbGpPWpGaD
Abiraterone—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000117	0.000939	CcSEcCtD
Abiraterone—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000111	0.00182	CbGpPWpGaD
Abiraterone—ALB—Folate Metabolism—CRP—chronic obstructive pulmonary disease	0.00011	0.00181	CbGpPWpGaD
Abiraterone—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000109	0.0018	CbGpPWpGaD
Abiraterone—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000109	0.0018	CbGpPWpGaD
Abiraterone—ALB—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000108	0.00179	CbGpPWpGaD
Abiraterone—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000106	0.000852	CcSEcCtD
Abiraterone—ALB—Vitamin B12 Metabolism—SERPINE1—chronic obstructive pulmonary disease	0.000104	0.00171	CbGpPWpGaD
Abiraterone—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000102	0.00168	CbGpPWpGaD
Abiraterone—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000101	0.000812	CcSEcCtD
Abiraterone—CYP17A1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	0.000101	0.00167	CbGpPWpGaD
Abiraterone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	9.95e-05	0.00164	CbGpPWpGaD
Abiraterone—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	9.82e-05	0.00162	CbGpPWpGaD
Abiraterone—CYP2C8—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	9.61e-05	0.00158	CbGpPWpGaD
Abiraterone—CYP2C8—Biological oxidations—GCLC—chronic obstructive pulmonary disease	9.5e-05	0.00157	CbGpPWpGaD
Abiraterone—Vomiting—Prednisone—chronic obstructive pulmonary disease	9.4e-05	0.000755	CcSEcCtD
Abiraterone—SULT2A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.4e-05	0.00155	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	9.39e-05	0.00155	CbGpPWpGaD
Abiraterone—Rash—Prednisone—chronic obstructive pulmonary disease	9.32e-05	0.000749	CcSEcCtD
Abiraterone—Dermatitis—Prednisone—chronic obstructive pulmonary disease	9.31e-05	0.000748	CcSEcCtD
Abiraterone—CYP17A1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	9.31e-05	0.00153	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—GCLC—chronic obstructive pulmonary disease	9.29e-05	0.00153	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—GC—chronic obstructive pulmonary disease	9.13e-05	0.00151	CbGpPWpGaD
Abiraterone—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	8.97e-05	0.00148	CbGpPWpGaD
Abiraterone—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	8.94e-05	0.00147	CbGpPWpGaD
Abiraterone—ALB—Selenium Micronutrient Network—CRP—chronic obstructive pulmonary disease	8.75e-05	0.00144	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—SERPINE2—chronic obstructive pulmonary disease	8.68e-05	0.00143	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	8.66e-05	0.00143	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—APIP—chronic obstructive pulmonary disease	8.55e-05	0.00141	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	8.49e-05	0.0014	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—CTGF—chronic obstructive pulmonary disease	8.48e-05	0.0014	CbGpPWpGaD
Abiraterone—ALB—Folate Metabolism—SERPINE1—chronic obstructive pulmonary disease	8.45e-05	0.00139	CbGpPWpGaD
Abiraterone—ALB—Platelet activation, signaling and aggregation—SERPINA1—chronic obstructive pulmonary disease	8.45e-05	0.00139	CbGpPWpGaD
Abiraterone—ALB—Vitamin B12 Metabolism—IL1B—chronic obstructive pulmonary disease	8.44e-05	0.00139	CbGpPWpGaD
Abiraterone—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	8.07e-05	0.00133	CbGpPWpGaD
Abiraterone—CYP2C8—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	7.99e-05	0.00132	CbGpPWpGaD
Abiraterone—CYP2D6—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	7.89e-05	0.0013	CbGpPWpGaD
Abiraterone—CYP2C8—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	7.88e-05	0.0013	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.81e-05	0.00129	CbGpPWpGaD
Abiraterone—CYP2D6—Biological oxidations—GCLC—chronic obstructive pulmonary disease	7.8e-05	0.00129	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—RAPGEF3—chronic obstructive pulmonary disease	7.58e-05	0.00125	CbGpPWpGaD
Abiraterone—ALB—Platelet activation, signaling and aggregation—TGFB2—chronic obstructive pulmonary disease	7.33e-05	0.00121	CbGpPWpGaD
Abiraterone—ALB—Platelet degranulation—SERPINE1—chronic obstructive pulmonary disease	7.25e-05	0.00119	CbGpPWpGaD
Abiraterone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	7.23e-05	0.00119	CbGpPWpGaD
Abiraterone—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	7.14e-05	0.00118	CbGpPWpGaD
Abiraterone—ALB—Response to elevated platelet cytosolic Ca2+—SERPINE1—chronic obstructive pulmonary disease	6.91e-05	0.00114	CbGpPWpGaD
Abiraterone—ALB—Folate Metabolism—IL1B—chronic obstructive pulmonary disease	6.87e-05	0.00113	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	6.76e-05	0.00112	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	6.75e-05	0.00111	CbGpPWpGaD
Abiraterone—ALB—Selenium Micronutrient Network—SERPINE1—chronic obstructive pulmonary disease	6.72e-05	0.00111	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	6.72e-05	0.00111	CbGpPWpGaD
Abiraterone—CYP2C8—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	6.66e-05	0.0011	CbGpPWpGaD
Abiraterone—CYP2C8—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	6.57e-05	0.00108	CbGpPWpGaD
Abiraterone—CYP2D6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	6.56e-05	0.00108	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.52e-05	0.00107	CbGpPWpGaD
Abiraterone—CYP2D6—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	6.47e-05	0.00107	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.43e-05	0.00106	CbGpPWpGaD
Abiraterone—ALB—Vitamin B12 Metabolism—TNF—chronic obstructive pulmonary disease	6.13e-05	0.00101	CbGpPWpGaD
Abiraterone—CYP2C8—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	6.12e-05	0.00101	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	6.09e-05	0.001	CbGpPWpGaD
Abiraterone—CYP2C8—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	6.04e-05	0.000995	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.99e-05	0.000987	CbGpPWpGaD
Abiraterone—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	5.86e-05	0.000966	CbGpPWpGaD
Abiraterone—CYP2C8—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	5.8e-05	0.000956	CbGpPWpGaD
Abiraterone—CYP2C8—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	5.72e-05	0.000943	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.68e-05	0.000936	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	5.66e-05	0.000933	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	5.62e-05	0.000926	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—GC—chronic obstructive pulmonary disease	5.51e-05	0.000908	CbGpPWpGaD
Abiraterone—CYP2D6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	5.47e-05	0.000901	CbGpPWpGaD
Abiraterone—ALB—Selenium Micronutrient Network—IL1B—chronic obstructive pulmonary disease	5.46e-05	0.000899	CbGpPWpGaD
Abiraterone—CYP2D6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	5.39e-05	0.000889	CbGpPWpGaD
Abiraterone—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	5.16e-05	0.00085	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	5.12e-05	0.000844	CbGpPWpGaD
Abiraterone—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	5.1e-05	0.00084	CbGpPWpGaD
Abiraterone—CYP2D6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	5.02e-05	0.000828	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.99e-05	0.000822	CbGpPWpGaD
Abiraterone—ALB—Platelet degranulation—VEGFA—chronic obstructive pulmonary disease	4.99e-05	0.000822	CbGpPWpGaD
Abiraterone—ALB—Folate Metabolism—TNF—chronic obstructive pulmonary disease	4.98e-05	0.000822	CbGpPWpGaD
Abiraterone—CYP2D6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.96e-05	0.000817	CbGpPWpGaD
Abiraterone—ALB—Vitamin B12 Metabolism—IL6—chronic obstructive pulmonary disease	4.94e-05	0.000815	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—GCLC—chronic obstructive pulmonary disease	4.93e-05	0.000813	CbGpPWpGaD
Abiraterone—CYP2D6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.76e-05	0.000785	CbGpPWpGaD
Abiraterone—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—chronic obstructive pulmonary disease	4.75e-05	0.000783	CbGpPWpGaD
Abiraterone—CYP2D6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.7e-05	0.000774	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—APIP—chronic obstructive pulmonary disease	4.67e-05	0.00077	CbGpPWpGaD
Abiraterone—ALB—Metabolism—APIP—chronic obstructive pulmonary disease	4.64e-05	0.000765	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	4.6e-05	0.000758	CbGpPWpGaD
Abiraterone—ALB—Platelet degranulation—TGFB1—chronic obstructive pulmonary disease	4.58e-05	0.000754	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—CTGF—chronic obstructive pulmonary disease	4.5e-05	0.000742	CbGpPWpGaD
Abiraterone—ALB—Folate Metabolism—TP53—chronic obstructive pulmonary disease	4.39e-05	0.000724	CbGpPWpGaD
Abiraterone—ABCC1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	4.39e-05	0.000724	CbGpPWpGaD
Abiraterone—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—chronic obstructive pulmonary disease	4.36e-05	0.000719	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—SERPINA1—chronic obstructive pulmonary disease	4.36e-05	0.000718	CbGpPWpGaD
Abiraterone—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	4.29e-05	0.000707	CbGpPWpGaD
Abiraterone—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	4.23e-05	0.000697	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.15e-05	0.000683	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	4.08e-05	0.000673	CbGpPWpGaD
Abiraterone—ALB—Folate Metabolism—IL6—chronic obstructive pulmonary disease	4.02e-05	0.000663	CbGpPWpGaD
Abiraterone—ALB—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	3.96e-05	0.000653	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—ALB—chronic obstructive pulmonary disease	3.86e-05	0.000636	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—APIP—chronic obstructive pulmonary disease	3.83e-05	0.000632	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—TGFB2—chronic obstructive pulmonary disease	3.78e-05	0.000623	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—NOS3—chronic obstructive pulmonary disease	3.69e-05	0.000608	CbGpPWpGaD
Abiraterone—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.57e-05	0.000589	CbGpPWpGaD
Abiraterone—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.53e-05	0.000581	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.46e-05	0.00057	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.41e-05	0.000562	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—HDAC2—chronic obstructive pulmonary disease	3.39e-05	0.000558	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	3.33e-05	0.000549	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	3.31e-05	0.000546	CbGpPWpGaD
Abiraterone—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.29e-05	0.000542	CbGpPWpGaD
Abiraterone—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.24e-05	0.000534	CbGpPWpGaD
Abiraterone—ALB—Platelet activation, signaling and aggregation—SERPINE1—chronic obstructive pulmonary disease	3.22e-05	0.00053	CbGpPWpGaD
Abiraterone—ALB—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	3.19e-05	0.000527	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.18e-05	0.000524	CbGpPWpGaD
Abiraterone—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.11e-05	0.000513	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.09e-05	0.00051	CbGpPWpGaD
Abiraterone—ALB—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.07e-05	0.000507	CbGpPWpGaD
Abiraterone—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.07e-05	0.000506	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	3.07e-05	0.000506	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—PLAUR—chronic obstructive pulmonary disease	3.05e-05	0.000503	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	3.05e-05	0.000503	CbGpPWpGaD
Abiraterone—ABCC1—Disease—HDAC2—chronic obstructive pulmonary disease	3.02e-05	0.000498	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.01e-05	0.000497	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.01e-05	0.000496	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—GC—chronic obstructive pulmonary disease	3.01e-05	0.000496	CbGpPWpGaD
Abiraterone—ALB—Metabolism—GC—chronic obstructive pulmonary disease	2.99e-05	0.000493	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—GCLC—chronic obstructive pulmonary disease	2.97e-05	0.00049	CbGpPWpGaD
Abiraterone—ABCC1—Disease—KL—chronic obstructive pulmonary disease	2.81e-05	0.000463	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.8e-05	0.000461	CbGpPWpGaD
Abiraterone—ALB—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.78e-05	0.000458	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.77e-05	0.000457	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—CTGF—chronic obstructive pulmonary disease	2.71e-05	0.000447	CbGpPWpGaD
Abiraterone—ABCC1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.64e-05	0.000435	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.54e-05	0.000418	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	2.51e-05	0.000413	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.5e-05	0.000412	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	2.47e-05	0.000407	CbGpPWpGaD
Abiraterone—ALB—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	2.38e-05	0.000393	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.3e-05	0.000378	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.23e-05	0.000367	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.22e-05	0.000365	CbGpPWpGaD
Abiraterone—ALB—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	2.21e-05	0.000365	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—MMP1—chronic obstructive pulmonary disease	2.18e-05	0.00036	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—PLAU—chronic obstructive pulmonary disease	2.14e-05	0.000353	CbGpPWpGaD
Abiraterone—ABCC1—Disease—ERBB3—chronic obstructive pulmonary disease	2.1e-05	0.000347	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.09e-05	0.000344	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.06e-05	0.000339	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—ALB—chronic obstructive pulmonary disease	2.05e-05	0.000338	CbGpPWpGaD
Abiraterone—ALB—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	2.03e-05	0.000335	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—NOS2—chronic obstructive pulmonary disease	1.97e-05	0.000324	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.96e-05	0.000323	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.92e-05	0.000316	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.82e-05	0.0003	CbGpPWpGaD
Abiraterone—ABCC1—Disease—NOS2—chronic obstructive pulmonary disease	1.75e-05	0.000289	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.66e-05	0.000274	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	1.66e-05	0.000273	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.64e-05	0.000271	CbGpPWpGaD
Abiraterone—ALB—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.63e-05	0.000269	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—GCLC—chronic obstructive pulmonary disease	1.62e-05	0.000268	CbGpPWpGaD
Abiraterone—ALB—Metabolism—GCLC—chronic obstructive pulmonary disease	1.62e-05	0.000266	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	1.61e-05	0.000266	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—NOS3—chronic obstructive pulmonary disease	1.58e-05	0.000261	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.51e-05	0.00025	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.5e-05	0.000247	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—CTGF—chronic obstructive pulmonary disease	1.48e-05	0.000244	CbGpPWpGaD
Abiraterone—ABCC1—Disease—SERPINE1—chronic obstructive pulmonary disease	1.48e-05	0.000244	CbGpPWpGaD
Abiraterone—ALB—Metabolism—CTGF—chronic obstructive pulmonary disease	1.47e-05	0.000243	CbGpPWpGaD
Abiraterone—ABCC1—Disease—NOS3—chronic obstructive pulmonary disease	1.41e-05	0.000233	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.37e-05	0.000225	CbGpPWpGaD
Abiraterone—ALB—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.36e-05	0.000224	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.35e-05	0.000222	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	1.33e-05	0.00022	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—ALB—chronic obstructive pulmonary disease	1.24e-05	0.000204	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	1.22e-05	0.000201	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.18e-05	0.000195	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—VEGFA—chronic obstructive pulmonary disease	1.14e-05	0.000188	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.14e-05	0.000188	CbGpPWpGaD
Abiraterone—ALB—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.13e-05	0.000187	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.12e-05	0.000185	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.12e-05	0.000185	CbGpPWpGaD
Abiraterone—ALB—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.12e-05	0.000184	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.05e-05	0.000173	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—TGFB1—chronic obstructive pulmonary disease	1.05e-05	0.000172	CbGpPWpGaD
Abiraterone—ALB—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.04e-05	0.000172	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.92e-06	0.000164	CbGpPWpGaD
Abiraterone—ALB—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.87e-06	0.000163	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.35e-06	0.000154	CbGpPWpGaD
Abiraterone—ABCC1—Disease—TGFB1—chronic obstructive pulmonary disease	9.33e-06	0.000154	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.22e-06	0.000152	CbGpPWpGaD
Abiraterone—ABCC1—Disease—EGFR—chronic obstructive pulmonary disease	9.15e-06	0.000151	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.82e-06	0.000145	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	8.72e-06	0.000144	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—TP53—chronic obstructive pulmonary disease	8.61e-06	0.000142	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.59e-06	0.000142	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.15e-06	0.000134	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	7.96e-06	0.000131	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.33e-06	0.000121	CbGpPWpGaD
Abiraterone—ABCC1—Disease—IL6—chronic obstructive pulmonary disease	7.03e-06	0.000116	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—ALB—chronic obstructive pulmonary disease	6.74e-06	0.000111	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—NOS3—chronic obstructive pulmonary disease	6.45e-06	0.000106	CbGpPWpGaD
Abiraterone—ALB—Metabolism—NOS3—chronic obstructive pulmonary disease	6.42e-06	0.000106	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.11e-06	0.000101	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.03e-06	9.94e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.62e-06	9.26e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	5.54e-06	9.13e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.33e-06	8.78e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	5.3e-06	8.73e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	3.62e-06	5.97e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	3.46e-06	5.71e-05	CbGpPWpGaD
